Literature DB >> 21277040

Lung cancer screening: what is the benefit and what do we do about it?

James L Mulshine, Rob J van Klaveren.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21277040     DOI： 10.1016/j.lungcan.2010.12.010

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  2 in total

1.  DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer.

Authors:  Georgios Nikolaidis; Olaide Y Raji; Soultana Markopoulou; John R Gosney; Julie Bryan; Chris Warburton; Martin Walshaw; John Sheard; John K Field; Triantafillos Liloglou
Journal:  Cancer Res       Date:  2012-09-07       Impact factor: 12.701

2.  The assessment of the role of baseline low-dose CT scan in patients at high risk of lung cancer.

Authors:  Katarzyna Kołaczyk; Anna Walecka; Tomasz Grodzki; Jacek Alchimowicz; Andrzej Smereczyński; Radosław Kiedrowicz
Journal:  Pol J Radiol       Date:  2014-07-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.